PDCI Market Access’s International Trends Series provides the results of an online survey conducted by PDCI between March 19, 2015 and March 25, 2015. Participants were public and private payers, and industry stakeholders in both Canada and Europe.
The final issue in this series reveals stakeholder’s perspectives on exclusivity agreements in both the public and private markets. Please click here a complimentary copy of the fifth and final issue, “Private Payer Exclusivity Agreements.”
Previously-released papers in the International Trends Series can be accessed at the following links:
- Delisting of Oncology Treatments
- Off-Label Prescribing Provisions
- Downgrading of Benefits
- Uptake of Biosimilars
- Private Payer Exclusivity Agreements
If you have any questions regarding any of the papers in this series, please contact Courtney Abunassar, PDCI’s Manager of Market Access and Policy Research.